2Seventy Capital Lease Obligations from 2010 to 2025
| TSVT Stock | USD 2.48 0.16 6.06% |
Capital Lease Obligations | First Reported 2010-12-31 | Previous Quarter 295.2 M | Current Value 235.5 M | Quarterly Volatility 65.7 M |
Check 2Seventy Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among 2Seventy Bio's main balance sheet or income statement drivers, such as Tax Provision of 0.0, Net Interest Income of 12.4 M or Depreciation And Amortization of 10.7 M, as well as many indicators such as Price To Sales Ratio of 2.29, Dividend Yield of 0.0 or PTB Ratio of 0.9. 2Seventy financial statements analysis is a perfect complement when working with 2Seventy Bio Valuation or Volatility modules.
2Seventy | Capital Lease Obligations |
Latest 2Seventy Bio's Capital Lease Obligations Growth Pattern
Below is the plot of the Capital Lease Obligations of 2Seventy Bio over the last few years. 2Seventy Bio capital lease obligations are the amount due for long-term lease agreements that are nearly equivalent to 2Seventy Bio asset purchases. For example, 2Seventy Bio can use a capital lease to finance the purchase of an asset without ever buying it. A capital lease gives companies such as 2Seventy Bio control over an asset for a big portion of its life. It is the total obligations of a company under capital leases, which are lease agreements that transfer substantially all risks and rewards of ownership to the lessee. 2Seventy Bio's Capital Lease Obligations historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in 2Seventy Bio's overall financial position and show how it may be relating to other accounts over time.
| Capital Lease Obligations | 10 Years Trend |
|
Capital Lease Obligations |
| Timeline |
2Seventy Capital Lease Obligations Regression Statistics
| Arithmetic Mean | 175,189,957 | |
| Geometric Mean | 165,403,007 | |
| Coefficient Of Variation | 37.50 | |
| Mean Deviation | 57,967,066 | |
| Median | 133,575,000 | |
| Standard Deviation | 65,689,023 | |
| Sample Variance | 4315T | |
| Range | 167.6M | |
| R-Value | 0.77 | |
| Mean Square Error | 1883.1T | |
| R-Squared | 0.59 | |
| Significance | 0.0005 | |
| Slope | 10,622,085 | |
| Total Sum of Squares | 64725.7T |
2Seventy Capital Lease Obligations History
About 2Seventy Bio Financial Statements
2Seventy Bio shareholders use historical fundamental indicators, such as Capital Lease Obligations, to determine how well the company is positioned to perform in the future. Although 2Seventy Bio investors may analyze each financial statement separately, they are all interrelated. The changes in 2Seventy Bio's assets and liabilities, for example, are also reflected in the revenues and expenses on on 2Seventy Bio's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Capital Lease Obligations | 295.2 M | 235.5 M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for 2Seventy Stock Analysis
When running 2Seventy Bio's price analysis, check to measure 2Seventy Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 2Seventy Bio is operating at the current time. Most of 2Seventy Bio's value examination focuses on studying past and present price action to predict the probability of 2Seventy Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 2Seventy Bio's price. Additionally, you may evaluate how the addition of 2Seventy Bio to your portfolios can decrease your overall portfolio volatility.